|
Platelet function inhibitors
Contributing journals to this collection:
Hypertension,
Circulation: Heart Failure,
Stroke,
Circulation Research,
Circulation: Arrhythmia and Electrophysiology,
Circulation: Cardiovascular Genetics,
Arteriosclerosis, Thrombosis, and Vascular Biology,
Circulation: Cardiovascular Outcomes and Quality,
Circulation,
Circulation: Cardiovascular Interventions,
and Circulation: Cardiovascular Imaging
Citations 1-10 of 358 total displayed.
- Articles
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
- Jeffrey S. Berger, Deepak L. Bhatt, Steven R. Steinhubl, Mingyuan Shao, P. Gabriel Steg, Gilles Montalescot, Werner Hacke, Keith A. Fox, A. Michael Lincoff, Eric J. Topol, Peter B. Berger for the CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance) Investigators
Circulation published November 23, 2009, doi:10.1161/CIRCULATIONAHA.109.866533
[Abstract]
- Articles
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Cornonary Disease: The ONSET/OFFSET Study
- Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler, Udaya S. Tantry, Tania Gesheff, Cheryl Wei, Renli Teng, Mark J. Antonino, Shankar B. Patil, Arun Karunakaran, Dean J. Kereiakes, Cordel Parris, Drew Purdy, Vance Wilson, Gary S. Ledley, and Robert F. Storey
Circulation published November 18, 2009, doi:10.1161/CIRCULATIONAHA.109.912550
[Abstract]
- Articles
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- Frederick G. Kushner, Mary Hand, Sidney C. Smith, Jr, Spencer B. King, III, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Jr, Lee A. Green, Judith S. Hochman, Alice K. Jacobs, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, and David O. Williams
Circulation published November 18, 2009, doi:10.1161/CIRCULATIONAHA.109.192663
[Abstract]
- Articles
Identification of a Novel 14-3-3 Binding Site Within the Cytoplasmic Domain of Platelet Glycoprotein Ib That Plays a Key Role in Regulating the von Willebrand Factor Binding Function of Glycoprotein Ib-IX
- Yanhong Yuan, Weilin Zhang, Rong Yan, Yi Liao, Lili Zhao, Changgeng Ruan, Xiaoping Du, and Kesheng Dai
Circ. Res. published October 29, 2009, doi:10.1161/CIRCRESAHA.109.204669
[Abstract]
- Original Articles
Common Variation in the Platelet Receptor P2RY12 Gene Is Associated With Residual On-Clopidogrel Platelet Reactivity in Patients Undergoing Elective Percutaneous Coronary Interventions
- Goran Rudez, Heleen J. Bouman, Jochem W. van Werkum, Frank W.G. Leebeek, Adrian Kruit, Hendrik J.T. Ruven, Jurriën M. ten Berg, Moniek P.M. de Maat, and Christian M. Hackeng
Circ Cardiovasc Genet 2009;2:515-521; published online before print as doi:10.1161/CIRCGENETICS.109.861799
[Abstract]
[Full text]
- Correspondence
Letter by de Miguel Castro et al Regarding Article, "Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay: A 12-Month Follow-Up"
- Antonio de Miguel Castro, Alejandro Diego Nieto, and Armando Pérez de Prado
Circulation 2009;120:e98, doi:10.1161/CIRCULATIONAHA.109.863886
[Full text]
- Original Articles
Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction: A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST)
- Michel R. Le May, George A. Wells, Chris A. Glover, Derek Y. So, Michael Froeschl, Jean-François Marquis, Edward R. O'Brien, Michele Turek, Allyson Thomas, Malek Kass, Sachin Jadhav, and Marino Labinaz
Circ Cardiovasc Interv 2009;2:330-338; published online before print as doi:10.1161/CIRCINTERVENTIONS.108.847582.108.847582
[Abstract]
[Full text]
- Correspondence
Response to Letter Regarding Article, "Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- Pieter J. Vlaar, Tone Svilaas, Kevin Damman, Bart J.G.L. de Smet, Hans L. Hillege, Felix Zijlstra, and Jan G.P. Tijssen
Circulation 2009;120:e27, doi:10.1161/CIRCULATIONAHA.109.853234
[Full text]
- Original Article
Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective PCI
- Goran Rudez, Heleen J. Bouman, Jochem W. van Werkum, Frank W.G. Leebeek, Adrian Kruit, Hendrik J.T. Ruven, Jurriën M. ten Berg, Moniek P.M. de Maat, and Christian M. Hackeng
Circ Cardiovasc Genet published July 24, 2009, doi:10.1161/CIRCGENETICS.109.861799
[Abstract]
- Original Articles
Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction: A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST)
- Michel R. Le May, George A. Wells, Chris A. Glover, Derek Y. So, Michael Froeschl, Jean-François Marquis, Edward R. O'Brien, Michele Turek, Allyson Thomas, Malek Kass, Sachin Jadhav, and Marino Labinaz
Circ Cardiovasc Interv published July 22, 2009, doi:10.1161/CIRCINTERVENTIONS.108.847582.108.847582
[Abstract]
|
|
